5月28日，艺康集团盘中上涨4.19%，报264.80美元/股，成交额2.59亿美元。
消息面上，瑞银近日将艺康集团评级从中性上调至买入，目标价从293美元上调至325美元。此前杰富瑞亦维持买入评级，目标价为345美元。据FactSet统计，分析师对艺康集团的平均评级为增持，平均目标价为320.89美元，当前股价较共识目标价仍有约21%的上行空间，多家机构看好态度明确，提振市场情绪。
艺康集团是全球可持续发展领导者，提供水处理、卫生和感染预防解决方案，服务覆盖食品、医疗、生命科学、酒店和工业市场。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.